126 related articles for article (PubMed ID: 2055236)
1. Studies on the emetic and antiemetic properties of zacopride and its enantiomers.
Sancilio LF; Pinkus LM; Jackson CB; Munson HR
Eur J Pharmacol; 1991 Jan; 192(3):365-9. PubMed ID: 2055236
[TBL] [Abstract][Full Text] [Related]
2. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
3. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
Sancilio LF; Pinkus LM; Jackson CB; Munson HR
Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
[TBL] [Abstract][Full Text] [Related]
4. Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
King GL; Landauer MR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1026-33. PubMed ID: 2359014
[TBL] [Abstract][Full Text] [Related]
5. The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.
Smith WL; Callaham EM; Alphin RS
J Pharm Pharmacol; 1988 Feb; 40(2):142-3. PubMed ID: 2897451
[TBL] [Abstract][Full Text] [Related]
6. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
King GL
J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
[TBL] [Abstract][Full Text] [Related]
7. The antiemetic profile of zacopride.
Smith WL; Alphin RS; Jackson CB; Sancilio LF
J Pharm Pharmacol; 1989 Feb; 41(2):101-5. PubMed ID: 2568416
[TBL] [Abstract][Full Text] [Related]
8. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
Bhandari P; Andrews PL
Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
10. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets.
Yamakuni H; Nakayama H; Matsui S; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2006 May; 101(1):99-102. PubMed ID: 16651699
[TBL] [Abstract][Full Text] [Related]
12. Dose-ranging trial of zacopride: the emetic antiemetic?
Pisters KM; Kris MG; Tyson LB; Clark RA; Gralla RJ
J Natl Cancer Inst; 1992 May; 84(9):717-8. PubMed ID: 1569606
[No Abstract] [Full Text] [Related]
13. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
Young R; Johnson DN
Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
[TBL] [Abstract][Full Text] [Related]
14. Prolonged anti-emetic activity and 5-HT3-receptor antagonism by BRL 46470 in conscious ferrets.
Bermudez J; Sanger GJ
J Pharm Pharmacol; 1994 Jun; 46(6):520-1. PubMed ID: 7932054
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers.
Pinkus LM; Sarbin NS; Gordon JC; Munson HR
Eur J Pharmacol; 1990 Apr; 179(1-2):231-5. PubMed ID: 2364986
[TBL] [Abstract][Full Text] [Related]
16. Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
Young R; Glennon RA
Eur J Pharmacol; 1992 Feb; 212(1):117-9. PubMed ID: 1555633
[TBL] [Abstract][Full Text] [Related]
17. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
[TBL] [Abstract][Full Text] [Related]
18. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Barnes JM; Barnes NM
Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
[TBL] [Abstract][Full Text] [Related]
19. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
Wade PR; Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
